Florens Lohrmann, Markus Hufnagel, Mirjam Kunze, Baharak Afshar, Roberta Creti, Antoaneta Detcheva, Jana Kozakova, Javier Rodriguez-Granger, Uffe B Skov Sørensen, Immaculada Margarit, Domenico Maione, Daniela Rinaudo, Graziella Orefici, John Telford, Manuel de la Rosa Fraile, Mogens Kilian, Androulla Efstratiou, Reinhard Berner, Pierrette Melin
PURPOSE: Group B streptococcus (GBS) remains a leading cause of invasive disease, mainly sepsis and meningitis, in infants < 3 months of age and of mortality among neonates. This study, a major component of the European DEVANI project (Design of a Vaccine Against Neonatal Infections) describes clinical and important microbiological characteristics of neonatal GBS diseases. It quantifies the rate of antenatal screening and intrapartum antibiotic prophylaxis among cases and identifies risk factors associated with an adverse outcome...
December 22, 2022: Infection